Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
7.79
-0.71 (-8.35%)
Feb 4, 2026, 2:19 PM EST - Market open
Kyntra Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 215.65 | -47.58 | -284.23 | -293.65 | -290.02 | -189.29 |
Depreciation & Amortization | 1.09 | 2.69 | 9.93 | 10.6 | 14.81 | 22.05 |
Loss (Gain) From Sale of Assets | 0.11 | 2.55 | 0 | -0 | 0.23 | 0.93 |
Asset Writedown & Restructuring Costs | 2.06 | - | 24.64 | - | 60 | - |
Loss (Gain) From Sale of Investments | 0 | -1.68 | -3.79 | 1.62 | 2.51 | 0.36 |
Loss (Gain) on Equity Investments | -3.79 | -3.97 | -2.64 | -1.57 | -1.01 | 0.2 |
Stock-Based Compensation | 5.57 | 25.22 | 50.77 | 65.6 | 71.16 | 72.72 |
Other Operating Activities | -41.63 | 2.23 | 9.99 | 1.04 | - | - |
Change in Accounts Receivable | 6.77 | -6.74 | 3.43 | 0.77 | 25.18 | -11.97 |
Change in Inventory | 9.75 | 22.28 | -1.7 | -11 | -14.16 | -9.18 |
Change in Accounts Payable | -3.09 | 14.51 | -15.51 | 5.91 | 0.81 | 17.73 |
Change in Unearned Revenue | -149.4 | -28.3 | -28.17 | -4.13 | 57.64 | 45.08 |
Change in Other Net Operating Assets | -60 | -119.22 | -77.75 | 78.89 | -9.38 | 132.97 |
Operating Cash Flow | -16.91 | -138 | -315.02 | -145.93 | -82.23 | 81.6 |
Capital Expenditures | -0.18 | -0.27 | -2.52 | -3.74 | -5.19 | -3.99 |
Sale of Property, Plant & Equipment | 0.21 | 1.05 | - | 0.01 | - | - |
Cash Acquisitions | - | - | 0.66 | - | - | - |
Sale (Purchase) of Intangibles | - | - | - | -35 | -25 | - |
Investment in Securities | -1.38 | 125.21 | 155.52 | 127.85 | -396.79 | 456.48 |
Investing Cash Flow | 88.85 | 125.99 | 153.66 | 89.12 | -426.97 | 452.49 |
Long-Term Debt Issued | - | - | 74.08 | - | - | - |
Long-Term Debt Repaid | - | -0.04 | -0.48 | -0.54 | -5.89 | -13.02 |
Net Debt Issued (Repaid) | -80.56 | -0.04 | 73.59 | -0.54 | -5.89 | -13.02 |
Issuance of Common Stock | 0.02 | 0.14 | 52.14 | 4.18 | 12.7 | 37.83 |
Repurchase of Common Stock | -0.08 | -0.35 | -0.24 | -5.17 | -7.37 | -11.46 |
Other Financing Activities | -5.4 | - | -2.75 | 48.3 | - | - |
Financing Cash Flow | -86.01 | -0.26 | 122.75 | 46.78 | -0.56 | 13.34 |
Foreign Exchange Rate Adjustments | 1.04 | 0.75 | -3.4 | -5.48 | 2.6 | 4.7 |
Net Cash Flow | -13.03 | -11.51 | -42.01 | -15.52 | -507.17 | 552.13 |
Free Cash Flow | -17.09 | -138.27 | -317.54 | -149.67 | -87.42 | 77.61 |
Free Cash Flow Margin | -205.97% | -466.78% | -678.46% | -106.35% | -37.15% | 44.02% |
Free Cash Flow Per Share | -4.23 | -34.55 | -81.58 | -39.98 | -23.66 | 21.59 |
Cash Interest Paid | 16.21 | 16.21 | 6.38 | 0.1 | 0.09 | 0.14 |
Levered Free Cash Flow | -91.71 | -150.77 | -273.99 | -104.83 | -98.14 | 129.76 |
Unlevered Free Cash Flow | -86.36 | -145.61 | -268.94 | -103.93 | -97.47 | 131.27 |
Change in Working Capital | -195.97 | -117.46 | -119.69 | 70.43 | 60.08 | 174.63 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.